Oor ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
BedryfBiotechnology
HoofkantoorSeattle, WA
Gestig2005
RegsvormC Corporation
StatusAktief
Resensies
Nog geen resensies nie. Met ALLOZYNE INC gewerk? Wees die eerste om jou ervaring te deel.
Sleutelgetalle
Meld aan om die kernsyfers te sien
Inkomste, netto inkomste en personeeltal van ALLOZYNE INC oor die jare, met hul bronne.
Meld aan Skep 'n rekening met u e-posDit is gratis
Deur voort te gaan, stem u in tot Heelky se Gebruikersooreenkoms, Privaatheidsbeleid en Koekiebeleid.
Regsinligting
| Regsnaam | ALLOZYNE INC |
|---|---|
| Regsvorm | C Corporation |
| SEC CIK | 1345630Bekyk op SEC EDGAR ↗ |
| Geregistreerde adres | Seattle, WA |
| Status | Aktief |
Bronne: SEC EDGAR · bygewerk Nov. 14, 2026
Kontak en skakels
Ligging
Seattle, WA
Is dit jou maatskappy?
Eis hierdie bladsy gratis op om jou logo, produkte, foto's en poste by te voeg, en om resensies te beantwoord.
Eis hierdie bladsy opSluit by Heelky aan om te verbind, aan te stel en te groei
Skep 'n gratis rekening om mense boodskappe te stuur, vir poste aansoek te doen en missies te plaas.
Sluit nou aan — dit is gratis